LUXEMBOURG–(BUSINESS WIRE)–Transplant Genomics (“TGI”), the transplant rejection diagnostics company committed to improving organ transplant outcomes worldwide, is pleased to introduce OmniGraf(TM), which combines the TruGraf(R) blood gene expression test and Viracor TRAC(R) donor-derived cell-free DNA assays. For renal transplant recipients, OmniGraf(TM) Kidney represents the first diagnostic tool that combines cell free DNA and gene expression data. When combined with TGI’s proprietary technology and